Hastings Center Report 46 (5):inside front cover-inside front (2016)
AbstractOver the past year media outlets and scientific and bioethics journals have reported about several medical and scientific innovations touted as having the potential to fundamentally change not only how diseases and disorders are diagnosed and treated but even how to alter the genomes of future generations. The purported “miracle” blood-testing technology of Theranos and the potential use of the genome editing technology CRISPR-Cas9 to modify human and nonhuman organisms reflect dramatic advances in scientific understanding about the biological mechanisms of humans and other living organisms. Yet evidence about whether these and other innovative biomedical technologies are safe and effective and lead to improved health outcomes for patients young and old is often in dispute. How to assess the safety and effectiveness of innovative biomedical technologies, who should be involved in that effort, and how to define risks and benefits of those technologies are questions at the intersection of values, interests, and politics.
Similar books and articles
Regulating Emerging and Future Technologies in the Present.Michael G. Bennett, Jake Gatof, Diana M. Bowman & Karinne Ludlow - 2015 - NanoEthics 9 (2):151-163.
CRISPR/Cas9 Genome Editing – New and Old Ethical Issues Arising From a Revolutionary Technology.Martina Baumann - 2016 - NanoEthics 10 (2):139-159.
Symbiotic Technology for Creating Social Innovation 30 Years in the Future.Shinichi Doi & Keiji Yamada - 2011 - AI and Society 26 (3):197-204.
The Nature of Technology: What It is and How It Evolves.W. Brian Arthur - 2009 - Free Press.
Technology and Well-Being- An Evocative Essay.Satabdi Roy Choudhury & Arup Barman - 2014 - Postmodern Openings 5 (2):15-37.
DNA Patents and Scientific Discovery and Innovation: Assessing Benefits and Risks.David B. Resnik - 2001 - Science and Engineering Ethics 7 (1):29-62.
The Relevance of Heidegger’s Philosophy of Technology for Biomedical Ethics.Fredrik Svenaeus - 2013 - Theoretical Medicine and Bioethics 34 (1):1-15.
Emerging Medical Technologies and Emerging Conceptions of Health.William E. Stempsey - 2006 - Theoretical Medicine and Bioethics 27 (3):227-243.
Innovative Surgery and the Precautionary Principle.Denise Meyerson - 2013 - Journal of Medicine and Philosophy 38 (6):jht047.
New Food Technologies in Europe, India and China.David Coles, Sachin Chaturvedi, Qiang Li & Miltos Ladikas - 2015 - In .
An Ethical Reflection on the Development of Bio-Medicine.Zhifeng Lu & Wen-Hsiang Chen - 2003 - Philosophy and Culture 30 (1):65-75.
Introduction: Evidence and Causality in the Sciences.Phyllis Illari & Federica Russo - 2014 - Topoi 33 (2):293-294.
Обґрунтування вибору стратегії забезпечення ефективності інноваційного проекту.Kateryna Khudoba - 2014 - Схід 6 (132):47-53.
Biomedical and Bioethical Issues in Parliamentary TA and in Health Technology Assessment.Leonhard Hennen - 2004 - Poiesis and Praxis 2 (s 2-3):207-220.
Added to PP
Historical graph of downloads